Every week I talk to clinical development leaders trying to move faster with AI.

Every data point is a person waiting for a better outcome. Here's why we made a film about hope before talking about technology.

Biorce stood out at ASCO 2026, taking the Aika 2.0 product launch into the city. Forget the Booth. This demo came with a seatbelt.

The FDA's RTCT initiative is bringing regulators closer to live trial data. The real question is whether trial infrastructure can keep pace.

Biorce is launching Aika 2.0 at ASCO 2026 with a ride experience, introducing the end-to-end operating system for clinical trials.

XTalks webinar with Pedro Coelho (Biorce CEO), Paolo Martini (Two Hundred Thousand Consulting LLC), and Bruno Gagnon (Spruce)

Adam Taylor (GSK) and Biorce CEO Pedro Coelho discuss trial inefficiencies, personalized medicine, and the role of defensible AI.

Biorce makes its mark with a bold conference as the life sciences industry gathers in Boston for a landmark week of events.

Pierre-Antoine André (IQVIA), with 25+ years across pharma, joins CEO Pedro Coelho to unpack where AI is truly creating impact.

Forbes Spain includes Biorce leadership team into the 100 most creative people in business 2026 (news article in Spanish).

The New Barcelona Post news article about Biorce (news article in Spanish).

Journal of Medical Internet Research highlighting Biorce.

Crunchbase news article featuring Biorce.

Markus Feuerecker (YZR Capital) joins Biorce CEO Pedro Coelho to discuss the role of investors beyond capital.

4YFN news article about Biorce winning the prestigious MWC 4YFN 2026 award.